Indian Army Department Of Military Affairs Medical Supplies Tender 2026: Branded Medicines & PPE, India, L1 Samples & 25% Optional Quantity Clause

Tender Overview

Indian Army through the Department Of Military Affairs invites bids for the supply of multiple medical commodities and PPE under a national procurement framework. The scope includes oral ivermectin paste 4.8 mg/ml in a 25 ml syringe, Povidone iodine 5% in 500 ml bottles, copper sulfate, zinc sulfate, ferrous sulfate powder, Ranitidine HCl 50 mg injectable (2 ml), Ketamine HCl injectable (10 ml), calamine powder, and disposable surgical caps with waterproof gowns. Bidder samples are required for medicines, and the L1 bidder must demonstrate quality and brand authenticity from reputed manufacturers (e.g., Intas, Cipla, Cadila, Zydus). The tender contemplates a 25% quantity variation, with delivery timelines anchored to the original delivery period and potential extension as described in the option clause. This is a goods-only procurement conducted nationwide with supplier qualification built around brand legitimacy and regulatory compliance.

• Organization: Indian Army, Department Of Military Affairs
• Product/Service: Branded medicines, injections, minerals, cosmetics, and PPE
• Location: India (national scope)
• Quantity/Value: Not disclosed; provides for 25% quantity variation during contract
• Key differentiator: Sample approval for medicines prior to order placement; reputed brand requirement
• Unique aspect: Option clause enabling quantity and delivery extensions under contracted rates

Technical Specifications & Requirements

• Item categories include: Oral ivermectin paste 4.8 mg/ml (25 ml syringe); Povidone iodine 5% (500 ml); Copper sulfate, Zinc sulfate, Ferrous sulfate powder; Ranitidine HCl 50 mg (injectable, 2 ml); Ketamine HCl injectable (10 ml vial); Calamine powder; Surgical caps disposable; Waterproof gowns.
• Brand expectations: Medicines must be from reputed brands such as Intas, Cipla, Cadila, Vetoquinol, Zydus; L1 must provide product samples for approval prior to order.
• Delivery terms: Option clause allows up to 25% quantity increase during contract; delivery period starts from the last date of original DO; additional time calculation follows formula with minimum 30 days.
• Compliance expectations: Goods-only scope; supplier must ensure brand legitimacy, regulatory compliance, and sample approvals prior to issuance of supply order.
• Quality/standards: No explicit IS/ISO codes listed; emphasis on branded medicines and proven quality from top manufacturers.
• BOQ/Quantity details: Not itemized in the BOQ; 10 total items listed with N/A quantities; procurement emphasizes supply readiness and brand certification.

Terms, Conditions & Eligibility

• EMD: Not disclosed in provided terms; bidders should expect an EMD as per standard Army procurement norms.
• Experience/Turnover: Suppliers to demonstrate capability with branded medicines and PPE; prior experience in medical supply to defense or government bodies is advantageous.
• Delivery: Delivery framework governed by option clause; initial delivery period to be specified in final contract; potential extensions allowed with contractor performance keeping contracted rates.
• Payment: Payment terms not specified in the public terms; typical government practice may include milestone-based or post-delivery settlement.
• Documents: Submit product samples for medicines; provide OEM authorizations; provide brand certificates, regulatory compliance documents, and supplier registrations; ensure GST and PAN validity.
• Penalties/Warranty: Not explicitly detailed; standard procurement penalties and warranty expectations to be clarified in the detailed RFP.
• Quote scope: Bid price must include all components for supply (FOB/Freight/Insurance to be clarified in final terms).